Stay updated on Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Sign up to get notified when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.

Latest updates to the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Contacts/Locations and Study Status sections (Revision: v3.4.2) to the study history. Removed the government funding notice (Revision: v3.4.1).SummaryDifference0.5%

- Check21 days agoChange DetectedThe page now shows a government-funding lapse notice and updates the revision to v3.4.1 (removing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedGlossary display has been added, the page uses green highlights for additions and red highlights for deletions, and the 'No FEAR Act Data' label has been capitalized.SummaryDifference0.4%

- Check35 days agoChange DetectedThe History page now includes Contacts/Locations and Study Status, and the revision is updated to v3.3.4 (replacing v3.3.3).SummaryDifference0.4%

- Check49 days agoChange DetectedA new update on 2026-01-05 adds Contacts/Locations and Study Status to the record history; the entry dated 2025-12-11 was removed.SummaryDifference0.2%

- Check63 days agoChange DetectedRevision: v3.3.3 added; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.